- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 101/02 - Halogens
Patent holdings for IPC class A61K 101/02
Total number of patents in this class: 251
10-year publication summary
|
12
|
9
|
8
|
14
|
11
|
15
|
15
|
22
|
25
|
11
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| GE Healthcare Limited | 628 |
16 |
| Sinotau Pharmaceuticals Group | 10 |
7 |
| Janssen Pharmaceutica N.V. | 3160 |
6 |
| Nihon Medi-physics Co., Ltd. | 176 |
5 |
| Technische Universitat Munchen | 713 |
5 |
| General Electric Company | 13938 |
4 |
| Actinium Pharmaceuticals Inc. | 145 |
4 |
| Progenics Pharmaceuticals, Inc. | 123 |
4 |
| University of Copenhagen | 441 |
4 |
| West China Hospital, Sichuan University | 240 |
4 |
| Blue Earth Diagnostics Limited | 35 |
3 |
| Danmarks Tekniske Universitet | 1040 |
3 |
| Hammersmith Imanet Limited | 17 |
3 |
| Medi-Physics, Inc. | 90 |
3 |
| Rigshospitalet | 131 |
3 |
| The United States of America, as represented by the Secretary, Department of Health and Human Services | 3014 |
3 |
| Jiangsu Institute of Nuclear Medicine | 5 |
3 |
| Bristol-myers Squibb Company | 4764 |
2 |
| F. Hoffmann-La Roche AG | 7800 |
2 |
| Hoffmann-La Roche Inc. | 3825 |
2 |
| Other owners | 165 |